Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Carboprost tromethamine 是合成的前列腺素 F2α的15-甲基类似物,能有效促进子宫的规律收缩,显着减少产中及产后出血量。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 313 | 现货 |
产品描述 | Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α and it can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery. |
体内活性 | Carboprost tromethamine has been accounted for to be 84-96% successful in the treatment of persistent hemorrhage because of uterine atony. Carboprost tromethamine has a significant effect on the prevention of postpartum hemorrhage in the cesarean section. It has a significant effect on improving the state of hypercoagulable blood and maintaining the stable hemodynamic state [1]. |
分子量 | 489.64 |
分子式 | C25H47NO8 |
CAS No. | 58551-69-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 125 mg/mL (255.29 mM), sonification is recommended.
DMSO: 99 mg/mL(202.19 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 2.0423 mL | 10.2116 mL | 20.4232 mL | 51.0579 mL |
5 mM | 0.4085 mL | 2.0423 mL | 4.0846 mL | 10.2116 mL | |
10 mM | 0.2042 mL | 1.0212 mL | 2.0423 mL | 5.1058 mL | |
20 mM | 0.1021 mL | 0.5106 mL | 1.0212 mL | 2.5529 mL | |
50 mM | 0.0408 mL | 0.2042 mL | 0.4085 mL | 1.0212 mL | |
100 mM | 0.0204 mL | 0.1021 mL | 0.2042 mL | 0.5106 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Carboprost tromethamine 58551-69-2 GPCR/G Protein Immunology/Inflammation Prostaglandin Receptor analogue postpartum law Carboprost uterus contraction blood hemorrhage Inhibitor inhibit hypercoagulable inhibitor